GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST 2017-2027 : Revenue Prospects by Disease Type (HIV/AIDS, Hepatitis, Tuberculosis, Malaria, Chlamydia), Technique (Immunoassay, Molecular Diagnostics, POC/Rapid Diagnosis, Microbiology), End User (Hospitals, Clinical Laboratories, Others) and Geography

感染症診断の世界市場2017-2027

◆タイトル:GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST 2017-2027 : Revenue Prospects by Disease Type (HIV/AIDS, Hepatitis, Tuberculosis, Malaria, Chlamydia), Technique (Immunoassay, Molecular Diagnostics, POC/Rapid Diagnosis, Microbiology), End User (Hospitals, Clinical Laboratories, Others) and Geography
◆商品コード:VGAIN712030
◆調査・発行会社:visiongain
◆発行日:2017年9月
◆ページ数:142
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Sigle User(1名閲覧)GBP2,499 ⇒換算¥369,852見積依頼/購入/質問フォーム
Five UserGBP2,999 ⇒換算¥443,852見積依頼/購入/質問フォーム
Site License(全社内共有可)GBP4,999 ⇒換算¥739,852見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

visiongain社が発行した当調査レポートでは、感染症診断の世界市場について調査・分析し、感染症診断の世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。
・レポートの概要
・イントロダクション
・感染症診断の世界市場
 (市場規模予測、市場動向、市場の成長要因・阻害要因など)
・感染症診断の世界市場:セグメント別市場分析
・感染症診断の世界市場:地域別市場分析、市場規模予測
・市場環境分析
・専門家の見解
・主要企業分析
・結論

Infectious Disease Diagnostics – our new study reveals trends, R&D progress, and predicted revenues
Where is the Infectious Disease Diagnostics market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 142-page report provides 83 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Infectious Disease Diagnostics market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are 3 segmentations of the infectious disease diagnostics market, with forecasts for 5 Diseases, 4 Techniques and 3 End Users, each forecasted at a global level.

Global Infectious Disease Diagnostic Market by Disease Type
• HIV/AIDS
• Hepatitis
• Tuberculosis
• Malaria
• Chlamydia

Global Infectious Disease Diagnostic Market by Technique
• Immunoassay
• Molecular Diagnostics
• POC/Rapid Diagnosis
• Microbiology

Global Infectious Disease Diagnostic Market by End User
• Hospitals
• Clinical Laboratories
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 11 leading national markets:
• US
• Germany
• The UK
• Italy
• Spain
• France
• Japan
• Brazil
• China
• India
• Russia

The report also includes profiles and for some of the leading companies in the Infectious Disease Diagnostics market, with a focus on this segment of these companies’ operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and the US in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth
Overall world revenue for Infectious Disease Diagnostics will surpass $13bn in 2017, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Infectious Disease Diagnostics Market report helps you
In summary, our 142-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for 3 segmentations of the Infectious Disease Diagnostics market, with forecasts for 5 Disease Types, 4 Techniques and 3 End Users – discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2027 for 11 key national markets – See forecasts for the infectious disease diagnostics market in the US, Brazil, Germany, France, the UK, Italy, Spain, China, India, Russia and Japan
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market – including company profiles for 9 of the major companies involved in the Infectious Disease Diagnostics market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain’s study is for everybody needing commercial analyses for the Infectious Disease Diagnostics market and leading companies. You will find data, trends and predictions.

Get our report today Global Infectious Disease Diagnostics Market Forecast 2017-2027: Revenue Prospects by Disease Type (HIV/AIDS, Hepatitis, Tuberculosis, Malaria, Chlamydia), Technique (Immunoassay, Molecular Diagnostics, POC/Rapid Diagnosis, Microbiology), End User (Hospitals, Clinical Laboratories, Others) and Geography.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

【レポートの目次】

1. Report Overview
1.1 Global Infectious Disease Diagnostics Market Overview
1.2 Global Infectious Disease Diagnostics Market Segmentation
1.3 Infectious Disease Diagnostics Report Structure
1.4 Why You Should Read This Report
1.5 How This Report Delivers
1.6 Key Questions Answered by This Analytical Report
1.7 Who is This Report For?
1.8 Methodology
1.8.1 Primary Research
1.8.2 Secondary Research
1.8.3 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain

2. The Global Infectious Disease Diagnostics Market (Disease Type) 2017-2027
2.1 An Introduction to Major Types of Infectious Diseases
2.2 HIV/AIDS
2.2.1 Antibody tests
2.2.2 Combination tests (Antigen/Antibody tests)
2.2.3 Nucleic Acid Tests (NATS)
2.3 Hepatitis
2.3.1 Enzyme test
2.3.2 Viral antibodies
2.4 Tuberculosis
2.5 Malaria
2.6 Chlamydia

3. The Global Infectious Disease Diagnostics Market (Technique) 2017-2027
3.1 An introduction to various types of techniques
3.2 Immunoassay
3.3 Molecular Diagnostics
3.4 Point of care/ rapid diagnosis
3.5 Microbiology
3.5.1 Culture
3.5.2 Microbial identification
3.6 Market Shares by Segment, 2017 and 2027
3.7 World Infectious Disease Diagnostics Market: Forecast by technique 2017-2027

4. The Global Infectious Disease Diagnostics Market (End User) 2017-2027
4.1 An introduction to end users
4.2 Hospitals
4.3 Clinical Laboratories
4.4 Others
4.5 Market Shares by end users, 2017-2027

5. The Global Infectious Disease Diagnostics Market (Geography) 2017-2027
5.1 An Introduction to the Infectious Disease Diagnostics Market by geography
5.2 United States Infectious Disease Diagnostics Market
5.2.1 United States Infectious Disease Diagnostics Market: by disease type
5.2.2 United States Infectious Disease Diagnostics Market: by end user
5.3 EU-5 Infectious Disease Diagnostics Market
5.3.1 EU-5 Infectious Disease Diagnostics Market: by disease type
5.3.2 EU-5 Infectious Disease Diagnostics Market: by End User
5.3.3 EU-5 Infectious Disease Diagnostics Market: by Country
5.3.3.1 Germany
5.3.3.2 France
5.3.3.3 United Kingdom
5.3.3.4 Spain
5.3.3.5 Italy
5.4 Japan Infectious Disease Diagnostics Market
5.4.1 Japan Infectious Disease Diagnostics Market: by disease type
5.4.2 Japan Infectious Disease Diagnostics Market: by End User
5.5 BRIC Infectious Disease Diagnostics Market
5.5.1 BRIC Infectious Disease Diagnostics Market: by disease type
5.5.2 BRIC Infectious Disease Diagnostics Market: by End User
5.5.3 BRIC Infectious Disease Diagnostics Market: by country
5.5.3.1 Brazil
5.5.3.2 India
5.5.3.3 Russia
5.5.3.4 China

6. Leading Companies in Infectious Disease Diagnostics Market
6.1 Introduction
6.2 Abbott Laboratories
6.2.1.1 Business Overview
6.2.1.2 Recent Financials
6.2.1.3 Product Offerings
6.2.1.4 Recent developments
6.3 Becton, Dickinson and Company
6.3.1.1 Business Overview
6.3.1.2 Recent Financials
6.3.1.3 Product Offerings
6.3.1.4 Recent developments
6.4 Biomérieux
6.4.1.1 Business Overview
6.4.1.2 Recent Financials
6.4.1.3 Product Offerings
6.4.1.4 Recent developments
6.5 Bio-Rad Laboratories
6.5.1.1 Business Overview
6.5.1.2 Recent Financials
6.5.1.3 Product Offerings
6.5.1.4 Recent developments
6.6 Alere, Inc
6.6.1.1 Business Overview
6.6.1.2 Recent Financials
6.6.1.3 Product Offerings
6.6.1.4 Recent developments
6.7 Siemens Healthcare
6.7.1.1 Business Overview
6.7.1.2 Recent Financials
6.7.1.3 Product Offerings
6.7.1.4 Recent Developments
6.8 Roche Diagnostics
6.8.1.1 Business Overview
6.8.1.2 Recent Financials
6.8.1.3 Product Offerings
6.8.1.4 Recent Developments
6.9 Danaher Corporation
6.9.1.1 Business Overview
6.9.1.2 Recent Financials:
6.9.1.3 Product and Service Offerings
6.9.1.4 Recent developments
6.10 Thermo-Fisher Scientific, Inc.
6.10.1.1 Recent Financials
6.10.1.2 Product Offerings
6.10.1.3 Recent Developments
6.11 Other Players of Importance within the Global Infectious Disease Diagnostics Industry

7. Qualitative Analysis
7.1 Porter’s Five Forces Analysis
7.1.1 Bargaining Power of Buyers
7.1.2 Bargaining Power of Suppliers
7.1.3 Industry Rivalry
7.1.4 Threat of New Entrants
7.1.5 Threat of Substitutes

8. Conclusion and Recommendation
8.1 Key Take-Away
8.2 Conclusion

9. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain Report Evaluation Form

List of Figures
Figure 2.1 Prevalence of HIV/Aids In Major Countries
Figure 2.2 Incidence Of Hiv Across Various Countries
Figure 2.3 Incidence of Hepatitis Forecast (2017-2027)
Figure 2.4 Forecasted Cases Of Tuberculosis (2017-2027)
Figure 2.5 Forecasted Cases Of Malaria (2017-2027)
Figure 2.6 Forecasted Cases Of Chlamydia (2017-2027)
Figure 3.1 Percentage Contribution Of Individual Segment- 2017
Figure 3.2 Percentage Contribution Of Individual Segment- 2027
Figure 3.3 Global Molecular Diagnostic Market Forecast,(Revenue, $ bn, AGR %, 2017-2027
Figure 3.4: Global Immunoassay Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Figure 3.5 Global Microbiology Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Figure 3.6: Global Rapid/POC Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Figure 4.1.: Global Infectious Disease Diagnostics end user: Hospitals Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Figure 4.2: Global Infectious Disease Diagnostics end user: Clinical Laboratories Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Figure 4.3.: Global Infectious Disease Diagnostics end user: Others Market Forecast, (Revenue, $bn, AGR % and CAGR %) 2017-2027
Figure 4.4: Infectious Disease Diagnostics End-User Market Share (%) 2017
Figure 4.5: Infectious Disease Diagnostics End-User Market Share (%) 2027
Figure 5.1. Infectious Disease Diagnostics Market, Regional Market Share, 2017 (%)
Figure 5.2. Infectious Disease Diagnostics Market, Regional Market Share, 2027 (%)
Figure 5.3: US Infectious Disease Diagnostics Market Forecast, (Revenue, $bn, AGR %) 2017-2027
Figure 5.4: US Infectious Disease Diagnostics Market Forecast (Disease Cases) 2017-2027
Figure 5.5: US Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn) 2017-2027
Figure 5.6: EU-5 Infectious Disease Diagnostics Market Forecast (Revenue, $bn, AGR %) 2017-2027
Figure 5.7. Infectious Disease Diagnostics market, Disease cases, 2017-2027, EU-5
Figure 5.8: EU-5 Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn) 2017-2027
Figure 5.9: EU-5 Infectious Disease Diagnostics Market Forecast, By Country (Revenue, $bn, AGR %) 2017-2027
Figure 5.10: Japanese Infectious Disease Diagnostics Market Forecast, By Country (Revenue, $bn, AGR %) 2017-2027
Figure 5.11. Infectious Disease Diagnostics Market Forecast (Disease Cases) 2017-2027, Japan
Figure 5.12: Japan Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn, AGR % and CAGR %) 2017-2027
Figure 5.13: BRIC Infectious Disease Diagnostics Market Forecast, By Market (Revenue, $bn, AGR %) 2017-2027
Figure 5.14: BRIC Infectious Disease Diagnostics Market Forecast, By Disease Cases 2017-2027
Figure 5.14: BRIC Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn) 2017-2027
Figure 5.15: BRIC Infectious Disease Diagnostics Market Forecast, By Country (Revenue, $bn) 2017-2027
Figure 7.1 Porter’s Five Forces Analysis for the Infectious Disease Diagnostics Market

List of Tables
Table 2.1 Prevalence Forecast of HIV/AIDS in major countries (Mn, 2017-2027)
Table 2.2 Incidence of HIV across various countries (2017-2027)
Table 2.3 Incidence of Hepatitis Forecast (2017-2027)
Table 2.4 Forecasted Incidence Of Tuberculosis (2017-2027)
Table 2.5 Forecasted Incidences of Malaria (2017-2027)
Table 2.6 Incidences of Chlamydia (2017-2027)
Table 3.1 infectious disease diagnoses By Share (%, 2017)
Table 3.2 infectious disease diagnoses By Share (%, 2027)
Table 3.3 Global Molecular Diagnostic Market Forecast,(Revenue, $ bn, AGR %, and CAGR %, 2017-2027
Table 3.4: Global Immunoassay Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Table 3.5: Global Microbiology Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Table 3.6: Global Rapid/POC Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Table 4.1: Global Infectious Disease Diagnostics end user: Hospitals Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Table 4.2: Global Infectious Disease Diagnostics: Clinical Laboratories Market Forecast, (Revenue $bn, AGR % and CAGR %) 2017-2027
Table 4.3.: Global Infectious Disease Diagnostics end user: Others Market Forecast, (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.1 : Infectious Disease Diagnostics Market Forecast, (Geographical Distribution, $bn, AGR %) 2017-2027
Table 5.2 : US Infectious Disease Diagnostics Market Forecast, (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.3: US Infectious Disease Diagnostics Market Forecast (Disease Cases) 2017-2027
Table 5.4: US Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.5 : EU-5 Infectious Disease Diagnostics Market Forecast (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.6: EU-5 Infectious Disease Diagnostics Market Forecast(Disease Cases) 2017-2027
Table 5.7: EU-5 Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.8: EU-5 Infectious Disease Diagnostics Market Forecast, By Country (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.9. Japanese Infectious Disease Diagnostics Market Forecast, (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.10. Infectious Disease Diagnostics Market Forecast (Disease Cases) 2017-2027, Japan
Table 5.11: Japan Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.12: BRIC Infectious Disease Diagnostics Market Forecast, (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.13 : BRIC Infectious Disease Diagnostics Market Forecast, By Disease Cases 2017-2027
Table 5.14: BRIC Infectious Disease Diagnostics Market Forecast, By End User (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 5.15: BRIC Infectious Disease Diagnostics Market Forecast, By Country (Revenue, $bn, AGR % and CAGR %) 2017-2027
Table 6.1 Abbott Laboratories– Key Facts
Table 6.2 Abbott Recent Financials
Table 6.3 Becton, Dickinson and Company– Key Facts
Table 6.4 Becton, Dickinson and Company Recent Financials
Table 6.5 bioMérieux S.A. – Key Facts
Table 6.6 bioMérieux S.A.Recent Financials
Table 6.7 Bio-Rad – Key Facts
Table 6.8 Bio-Rad – Recent Financials
Table 6.9 Alere – Key Facts
Table 6.10 Alere – Recent Financials
Table 6.11 Siemens Healthcare – Key Facts
Table 6.12 Siemens Healthcare – Recent Financials
Table 6.13 Roche Diagnostics – Key Facts
Table 6.14 Danaher Corporation– Key Facts
Table 6.15 Danaher Corporation.– Recent Financials
Table 6.16 Thermo Fisher Scientific Inc.– Key Facts
Table 6.17 Thermo Fisher Scientific Inc.– Recent Financials
Table 6.18: Companies of interest in the Infectious Disease Diagnostics Market

★調査レポート[感染症診断の世界市場2017-2027] ( GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST 2017-2027 : Revenue Prospects by Disease Type (HIV/AIDS, Hepatitis, Tuberculosis, Malaria, Chlamydia), Technique (Immunoassay, Molecular Diagnostics, POC/Rapid Diagnosis, Microbiology), End User (Hospitals, Clinical Laboratories, Others) and Geography / VGAIN712030) 販売に関する免責事項
[感染症診断の世界市場2017-2027] ( GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST 2017-2027 : Revenue Prospects by Disease Type (HIV/AIDS, Hepatitis, Tuberculosis, Malaria, Chlamydia), Technique (Immunoassay, Molecular Diagnostics, POC/Rapid Diagnosis, Microbiology), End User (Hospitals, Clinical Laboratories, Others) and Geography / VGAIN712030) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆